EMA
- Status: approved
🇪🇺 Rimegepant 75mg every other day dosing in European Union
Rimegepant 75mg every other day dosing (rimegepant-75mg-every-other-day-dosing) regulatory status in European Union.
Marketing authorisation
Rimegepant 75mg every other day dosing in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Rimegepant 75mg every other day dosing approved in European Union?
Yes. EMA has authorised it.
Who is the marketing authorisation holder for Rimegepant 75mg every other day dosing in European Union?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.